Andrew Lam describes his career journey that started with a Doctor of Pharmacy education before working in industry, the investment world, back in industry, and then settling at Ally Bridge. He discusses the successful investments Ally Bridge has made in biotech, including in technologies like radiopharmaceuticals and ADCs, and the concept of being a bridge to China innovation.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from BioVenture VoiCes with Chris Garabedian
Episode 46: Catalys Pacific's BT Slingsby
Episode 45: Catalio Capital Management's George Petrocheilos
Episode 44: BainCapital's Adam Koppel
Episode 43: Lightstone Venture's Mike Carusi
Get summaries like this every morning.
Free AI-powered recaps of BioVenture VoiCes with Chris Garabedian and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.